| Drug Name | (Yasmin ® (DROSPIRENONE, ETHINYLESTRADIOL |
|---|---|
| Drug Class |
Hormone
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Gynecology
|
| Risk |
Risk of venous thromboembolism ( VTE ) |
| Dear Healthcare provider letter DHPC |
|